Suchergebnisse - "Norton, Thomas"

PubPharm (4)

1

Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection : A Phase 2 Dose-Ranging Randomized Clinical Trial

enthalten in: JAMA network open | 2022

von Portal-Celhay, C. | Forleo-Neto, E. | Eagan, W. | +127

2

The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies

enthalten in: Cell | 2021

von Copin, R. | Baum, A. | Wloga, E. | +34

3

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2021

von Weinreich, D. | Sivapalasingam, S. | Norton, T. | +131

CommentIn: N Engl J Med. 2021 Jan 21;384(3):289-291. - PMID 33471984

4

Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma

enthalten in: Cancer chemotherapy and pharmacology | 2017

von Badruddoja, M. | Pazzi, M. | Sanan, A. | +6

ErratumIn: Cancer Chemother Pharmacol. 2018 Jan;81(1):223. - PMID 29034406

1
[1]